Literature DB >> 22947367

Improved heart rate dynamics in patients undergoing percutaneous renal denervation.

Frank Himmel, Joachim Weil, Michael Reppel, Kai Mortensen, Klaas Franzen, Leidinger Ansgar, Heribert Schunkert, Frank Bode.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22947367      PMCID： PMC8816426          DOI： 10.1111/j.1751-7176.2012.00658.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  5 in total

1.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Authors:  Murray D Esler; Henry Krum; Paul A Sobotka; Markus P Schlaich; Roland E Schmieder; Michael Böhm
Journal:  Lancet       Date:  2010-11-17       Impact factor: 79.321

2.  Renal sympathetic-nerve ablation for uncontrolled hypertension.

Authors:  Markus P Schlaich; Paul A Sobotka; Henry Krum; Elisabeth Lambert; Murray D Esler
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

Review 3.  Treatment strategies for resistant arterial hypertension.

Authors:  Felix Mahfoud; Frank Himmel; Christian Ukena; Heribert Schunkert; Michael Böhm; Joachim Weil
Journal:  Dtsch Arztebl Int       Date:  2011-10-28       Impact factor: 5.594

4.  Alterations in heart rate variability and its circadian rhythm in hypertensive patients with left ventricular hypertrophy free of coronary artery disease.

Authors:  S Chakko; R F Mulingtapang; H V Huikuri; K M Kessler; B J Materson; R J Myerburg
Journal:  Am Heart J       Date:  1993-12       Impact factor: 4.749

5.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321
  5 in total
  7 in total

Review 1.  Review of the state of renal nerve ablation for patients with severe and resistant hypertension.

Authors:  Vinay Gulati; William B White
Journal:  J Am Soc Hypertens       Date:  2013-08-15

Review 2.  Renal denervation therapy for resistant hypertension: a clinical update.

Authors:  C V S Ram; A S Kumar
Journal:  J Hum Hypertens       Date:  2014-03-06       Impact factor: 3.012

Review 3.  Central Sympathetic Inhibition: a Neglected Approach for Treatment of Cardiac Arrhythmias?

Authors:  Francesca Cagnoni; Maurizio Destro; Erika Bontempelli; Giovanni Locatelli; Dagmara Hering; Markus P Schlaich
Journal:  Curr Hypertens Rep       Date:  2016-02       Impact factor: 5.369

Review 4.  The role of renal denervation for the treatment of resistant hypertension.

Authors:  A J A McLellan; P M Kistler; A S Walton; M P Schlaich
Journal:  J Hum Hypertens       Date:  2013-10-03       Impact factor: 3.012

5.  Drug-resistant hypertensive patients responding to multielectrode renal denervation exhibit improved heart rate dynamics and reduced arrhythmia burden.

Authors:  C Tsioufis; V Papademetriou; D Tsiachris; K Dimitriadis; A Kasiakogias; A Kordalis; V Antonakis; A Kefala; C Thomopoulos; I Kallikazaros; E O-Y Lau; C Stefanadis
Journal:  J Hum Hypertens       Date:  2014-03-13       Impact factor: 3.012

Review 6.  Renal sympathetic denervation for treatment of resistant hypertension: a systematic review.

Authors:  Priyanka Gosain; Pranav S Garimella; Peter D Hart; Rajender Agarwal
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-10-26       Impact factor: 3.738

Review 7.  Renal denervation after Symplicity HTN-3: an update.

Authors:  Alexandre Persu; Yu Jin; Fadl Elmula Mohamed Fadl Elmula; Lotte Jacobs; Jean Renkin; Sverre Kjeldsen
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.